|
|
Volumn 97, Issue 13, 2005, Pages 955-
|
|
Hormone replacement therapy for breast cancer survivors: An answered question?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BISPHOSPHONIC ACID DERIVATIVE;
HORMONE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
BREAST CANCER;
CANCER PREVENTION;
CANCER SURVIVAL;
CLINICAL TRIAL;
FEMALE;
FOLLOW UP;
HEART DISEASE;
HORMONE SUBSTITUTION;
HUMAN;
LONG TERM CARE;
MENOPAUSAL SYNDROME;
NOTE;
POSTMENOPAUSE OSTEOPOROSIS;
PRIORITY JOURNAL;
PUBLISHING;
SAFETY;
SWEDEN;
UNITED STATES;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CONTROLLED CLINICAL TRIAL;
ESTROGEN THERAPY;
EUROPE;
RANDOMIZED CONTROLLED TRIAL;
SURVIVOR;
TUMOR RECURRENCE;
BREAST NEOPLASMS;
ESTROGEN REPLACEMENT THERAPY;
EUROPE;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
RANDOMIZED CONTROLLED TRIALS;
SURVIVORS;
|
|
EID: 21244474058
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/dji198 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|